Tuberculosis: Evidence Review for Newly Arriving Immigrants and Refugees
This evidence review by Greenaway C et al., published in CMAJ (2011), provides a systematic examination of tuberculosis epidemiology in immigrant and refugee populations arriving in Canada. It outlines indications for latent TB screening, comparing tuberculin skin test (TST) and interferon-gamma release assay (IGRA) approaches, and presents management pathways and treatment protocols.
The review includes pediatric-specific considerations, noting that IGRA is not recommended for children under 2 years of age and that TST is appropriate from 6 months to 2 years. It also references high-TB incidence country lists to guide screening decisions.
Source: Greenaway C et al., CMAJ 2011 183(12):E939–E951
Related Guides
Tuberculosis Evidence Review — Newly Arriving Immigrants
Systematic review of TB epidemiology in immigrants and refugees, covering latent TB screening, TST vs IGRA, treatment protocols, and pediatric considerations.
Varicella - Management of Non-Immune Refugee Patients
Management of varicella-non-immune refugee patients, including immunization referral pathways and handling of indeterminate serology results.
Pediatric-Specific Recommendations
Pediatric guidance for refugee children - TB screening, hearing and dental referral, parasite testing, vitamin D, G6PD, tinea capitis, and lead poisoning.